These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38708616)

  • 61. Incidence and survival patterns of rare anal canal neoplasms using the surveillance epidemiology and end results registry.
    Metildi C; McLemore EC; Tran T; Chang D; Cosman B; Ramamoorthy SL; Saltzstein SL; Sadler GR
    Am Surg; 2013 Oct; 79(10):1068-74. PubMed ID: 24160801
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Peritoneal Metastases from Gastroenteropancreatic Neuroendocrine Tumors: Incidence, Risk Factors and Prognosis.
    Madani A; Thomassen I; van Gestel YRBM; van der Bilt JDW; Haak HR; de Hingh IHJT; Lemmens VEPP
    Ann Surg Oncol; 2017 Aug; 24(8):2199-2205. PubMed ID: 28204963
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Trend of gastric cancer incidence and death rate in adolescents and young adults: A retrospective cohort study based on the Surveillance, Epidemiology, and End Results (SEER) database.
    Wen J; Shen H
    J Gastroenterol Hepatol; 2023 Mar; 38(3):393-403. PubMed ID: 36403128
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Early-Onset Colorectal Cancer: Are Neuroendocrine Tumors or Adenocarcinomas the Culprit? Analysis of the Largest U.S. Cancer Incidence Database, 2001-2020.
    Abboud Y; Fraser M; Qureshi I; Hajifathalian K
    J Clin Med; 2024 Feb; 13(4):. PubMed ID: 38398411
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Trends in Melanoma Incidence, Prevalence, Stage at Diagnosis, and Survival: An Analysis of the United States Cancer Statistics (USCS) Database.
    Okobi OE; Abreo E; Sams NP; Chukwuebuni OH; Tweneboa Amoako LA; Wiredu B; Uboh EE; Ekechi VC; Okafor AA
    Cureus; 2024 Oct; 16(10):e70697. PubMed ID: 39493095
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prostate cancer epidemiology and prognostic factors in the United States.
    Abudoubari S; Bu K; Mei Y; Maimaitiyiming A; An H; Tao N
    Front Oncol; 2023; 13():1142976. PubMed ID: 37901326
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Epidemiology and treatment of lacrimal gland tumors: a population-based cohort analysis.
    Mallen-St Clair J; Arshi A; Tajudeen B; Abemayor E; St John M
    JAMA Otolaryngol Head Neck Surg; 2014 Dec; 140(12):1110-6. PubMed ID: 25393577
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013.
    Lim H; Devesa SS; Sosa JA; Check D; Kitahara CM
    JAMA; 2017 Apr; 317(13):1338-1348. PubMed ID: 28362912
    [TBL] [Abstract][Full Text] [Related]  

  • 69. EPIDEMIOLOGY OF GASTROINTESTINAL NEUROENDOCRINE TUMORS IN A U.S. COMMERCIALLY INSURED POPULATION.
    Broder MS; Cai B; Chang E; Neary MP
    Endocr Pract; 2017 Oct; 23(10):1210-1216. PubMed ID: 28704096
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prognostic and metastasis-related factors in colorectal neuroendocrine tumors: A cross-sectional study based on the Surveillance, Epidemiology and End Results.
    Zou J; Chen S; Lian G; Li R; Li Y; Huang K; Chen Y
    Oncol Lett; 2019 Nov; 18(5):5129-5138. PubMed ID: 31612024
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Incidence and survival trends for gastric neuroendocrine neoplasms: An analysis of 3523 patients in the SEER database.
    Cao LL; Lu J; Lin JX; Zheng CH; Li P; Xie JW; Wang JB; Chen QY; Lin M; Tu RH; Huang CM
    Eur J Surg Oncol; 2018 Oct; 44(10):1628-1633. PubMed ID: 29983275
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The risk and prognostic factors for G1 pancreatic neuroendocrine tumors: A retrospective analysis of the SEER database.
    Wu Z; Qiu X; Zhi Y; Shi X; Lv G
    Front Oncol; 2022; 12():993524. PubMed ID: 36276109
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Patterns of Lymph Node Metastasis and Optimal Surgical Strategy in Small (≤20 mm) Gastroenteropancreatic Neuroendocrine Tumors.
    Cai Y; Liu Z; Jiang L; Ma D; Zhou Z; Ju H; Zhu Y
    Front Endocrinol (Lausanne); 2022; 13():871830. PubMed ID: 35937823
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Invasive Cancer Incidence, 2004-2013, and Deaths, 2006-2015, in Nonmetropolitan and Metropolitan Counties - United States.
    Henley SJ; Anderson RN; Thomas CC; Massetti GM; Peaker B; Richardson LC
    MMWR Surveill Summ; 2017 Jul; 66(14):1-13. PubMed ID: 28683054
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Survival outcomes for lung neuroendocrine tumors in California differ by sociodemographic factors.
    Mulvey CK; Paciorek A; Moon F; Steiding P; Shih B; Gubens MA; Zhang L; Bergsland EK; Cheng I
    Endocr Relat Cancer; 2024 Jan; 31(1):. PubMed ID: 37882324
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Incidence trends of lung and gastroenteropancreatic neuroendocrine neoplasms in Switzerland.
    Alwan H; La Rosa S; Andreas Kopp P; Germann S; Maspoli-Conconi M; Sempoux C; Bulliard JL
    Cancer Med; 2020 Dec; 9(24):9454-9461. PubMed ID: 33078908
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer.
    Edwards BK; Noone AM; Mariotto AB; Simard EP; Boscoe FP; Henley SJ; Jemal A; Cho H; Anderson RN; Kohler BA; Eheman CR; Ward EM
    Cancer; 2014 May; 120(9):1290-314. PubMed ID: 24343171
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Competing Mortality in Patients With Neuroendocrine Tumors.
    Low SK; Giannis D; Bahaie NS; Trong BLH; Moris D; Huy NT
    Am J Clin Oncol; 2019 Aug; 42(8):668-674. PubMed ID: 31343423
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Incidence, survival, and prognostic factors for patients with gastrointestinal mixed neuroendocrine non-neuroendocrine neoplasms: a SEER population-based study.
    Xu B; Zhang F; Wu R; Peng Y; Mao Z; Tong S
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):15657-15669. PubMed ID: 37656242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.